Leonardo Mousinho Guerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Leonardo Mousinho Guerra has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- André Furugen Cesar de Andrade
Universidade de São Paulo, Brasil
1 shared publication - Fernanda Amate Lopes
Universidade Municipal de São Caetano do Sul, Brazil
1 shared publication - Luciano Miller Reis Rodrigues
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
1 shared publication - Rafael Carboni DE Souza
Faculdade de Medicina DO ABC, Brazil
1 shared publication - Wilker Herkson DE Almeida Oliveira
Faculdade de Medicina DO ABC, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Coluna/Columna
- Vol. 23 (1) , e271651
MEDICINES FOR MANAGING LOWER PAIN IN PATIENTS WITH FAILED BACK SURGERY SYNDROME TREATED WITH NEUROMODULATION
Objective: To compare the use of drugs to control low back pain in the pre- and postoperative periods among patients with Failed Back Surgery Syndrome (FBSS) undergoing neuromodulation. Methods: Retrospective observational study analyzing the medical records of patients with FBSS who underwent neuromodulation, followed up in an outpatient clinic from 2018 to 2020. The characteristics of the patients were evaluated: the use of medications, quality of life through the results of the Short Form 36 Health Survey Questionnaire (SF-36), and functional capacity using the Oswestry Disability Index (ODI) in the pre-surgical and post-surgical periods (06 months, 01 year). The criterion for establishing statistical significance was p≤0.05. Results: 56 patients were evaluated. There was a reduction in the use of pain control drugs after the institution of neuromodulation, including in the opioid class (d=0.81). An improvement was also observed in the ODI scores (p<0.001) and all the SF-36 domains (p<0.02) in the postoperative periods investigated. Conclusion: The data suggest that neuromodulation positively impacted back pain by reducing medication use and improving functional capacity and quality of life. Level of Evidence IV; Retrospective, Observational Study.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Coluna/Columna
- Vol. 23 (1) , e271651
Open AccessMEDICINES FOR MANAGING LOWER PAIN IN PATIENTS WITH FAILED BACK SURGERY SYNDROME TREATED WITH NEUROMODULATION
Objective: To compare the use of drugs to control low back pain in the pre- and postoperative periods among patients with Failed Back Surgery Syndrome (FBSS) undergoing neuromodulation. Methods: Retrospective observational study analyzing the medical records of patients with FBSS who underwent neuromodulation, followed up in an outpatient clinic from 2018 to 2020. The characteristics of the patients were evaluated: the use of medications, quality of life through the results of the Short Form 36 Health Survey Questionnaire (SF-36), and functional capacity using the Oswestry Disability Index (ODI) in the pre-surgical and post-surgical periods (06 months, 01 year). The criterion for establishing statistical significance was p≤0.05. Results: 56 patients were evaluated. There was a reduction in the use of pain control drugs after the institution of neuromodulation, including in the opioid class (d=0.81). An improvement was also observed in the ODI scores (p<0.001) and all the SF-36 domains (p<0.02) in the postoperative periods investigated. Conclusion: The data suggest that neuromodulation positively impacted back pain by reducing medication use and improving functional capacity and quality of life. Level of Evidence IV; Retrospective, Observational Study.